SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+1.82%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$179M
AUM Growth
+$179M
(-3.8%)
Cap. Flow
-$91.2M
Cap. Flow
% of AUM
-50.95%
Top 10 Holdings %
Top 10 Hldgs %
68.1%
Holding
152
New
35
Increased
13
Reduced
11
Closed
22
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$24.4M |
| 2 |
AGEN
Agenus
AGEN
|
$4.89M |
| 3 |
MannKind Corp
MNKD
|
$4.59M |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$3.89M |
| 5 |
Sarepta Therapeutics
SRPT
|
$3.17M |
Top Sells
| 1 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$28.7M |
| 2 |
AbbVie
ABBV
|
$14.7M |
| 3 |
Zoetis
ZTS
|
$14.2M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$11.5M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$10.4M |
Sector Composition
| 1 | Healthcare | 90.22% |
| 2 | Financials | 0.57% |
| 3 | Technology | 0.56% |
| 4 | Consumer Staples | 0% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
InspireMD
NSPR
$101M
| – | – |
0
-106,800
| -100% | -$235K |
|
152
iShares S&P 100 ETF
OEF
$22.1B
| – | – |
0
| – | – |
|